Jonathan M. Flanagan

1.2k total citations
31 papers, 789 citations indexed

About

Jonathan M. Flanagan is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, Jonathan M. Flanagan has authored 31 papers receiving a total of 789 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Genetics, 22 papers in Hematology and 12 papers in Molecular Biology. Recurrent topics in Jonathan M. Flanagan's work include Hemoglobinopathies and Related Disorders (24 papers), Iron Metabolism and Disorders (13 papers) and Blood groups and transfusion (8 papers). Jonathan M. Flanagan is often cited by papers focused on Hemoglobinopathies and Related Disorders (24 papers), Iron Metabolism and Disorders (13 papers) and Blood groups and transfusion (8 papers). Jonathan M. Flanagan collaborates with scholars based in United States, Brazil and Australia. Jonathan M. Flanagan's co-authors include Russell E. Ware, Thad A. Howard, Banu Aygün, Vivien Sheehan, Lisa Bouchier‐Hayes, Nicole A. Mortier, Jin He, Jenny M. Despotovic, Christopher P. Dillon and Helen M. Beere and has published in prestigious journals such as Blood, Molecular Cell and The Journal of Immunology.

In The Last Decade

Jonathan M. Flanagan

29 papers receiving 777 citations

Peers

Countries citing papers authored by Jonathan M. Flanagan

Since Specialization

Citations

This map shows the geographic impact of Jonathan M. Flanagan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan M. Flanagan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan M. Flanagan more than expected).

Fields of papers citing papers by Jonathan M. Flanagan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan M. Flanagan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan M. Flanagan. The network helps show where Jonathan M. Flanagan may publish in the future.

Co-authorship network of co-authors of Jonathan M. Flanagan

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan M. Flanagan. A scholar is included among the top collaborators of Jonathan M. Flanagan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan M. Flanagan. Jonathan M. Flanagan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Genetic variants in canonical Wnt signaling pathway associated with pediatric immune thrombocytopenia 2024 ·Blood Advances ·(unknown), (unknown), Jonathan M. Flanagan, Rachael F. Grace, Michele P. Lambert, (unknown), Melissa J. Rose, Kristin A. Shimano, Omar Niss, Cindy Neunert, Taizo A. Nakano, (unknown), (unknown), Susan E. Kirk, Ellis J. Neufeld, Jenny M. Despotovic, Michael E. Scheurer, Amanda B. Grimes	4
2	Neighborhood Disadvantage Increases Risk of Adverse Clinical Events in Children with Sickle Cell Disease 2023 ·Blood ·(unknown), (unknown), Jonathan M. Flanagan	1
3	Genome‐wide association study of early ischaemic stroke risk in Brazilian individuals with sickle cell disease implicates ADAMTS2 and CDK18 and uncovers novel loci 2023 ·British Journal of Haematology ·Eric J. Earley, Shannon Kelly, Fang Fang, Cecília Salete Alencar, Daniela de Oliveira Werneck Rodrigues, (unknown), Jonathan M. Flanagan, Russell E. Ware, Xu Zhang, Victor R. Gordeuk, Mark T. Gladwin, Yingze Zhang, Mehdi Nouraie, Sergeï Nekhai, Éster Cerdeira Sabino, Brian Custer, Carla Luana Dinardo, Grier P. Page	3
4	Clinical and Hematopoietic Profiles Associated with Sustained Hydroxyurea Response for Patients with Sickle Cell Disease 2023 ·Blood ·(unknown), (unknown), (unknown), Titilope Fasipe, Jonathan M. Flanagan	0
5	The NLRP3 inflammasome fires up heme-induced inflammation in hemolytic conditions 2022 ·Translational research ·(unknown), (unknown), Jonathan M. Flanagan, (unknown), Lisa Bouchier‐Hayes	13
6	Vascular Transcriptomics: Investigating Endothelial Activation and Vascular Dysfunction Using Blood Outgrowth Endothelial Cells, Organ‐Chips, and RNA Sequencing 2022 ·Current Protocols ·Tanmay Mathur, Ankit Kumar, Jonathan M. Flanagan, Abhishek Jain	2
7	Noncanonical Roles of Caspase-4 and Caspase-5 in Heme-Driven IL-1β Release and Cell Death 2021 ·The Journal of Immunology ·(unknown), (unknown), Brittany A. Rohrman, (unknown), (unknown), John D. Belcher, Gregory M. Vercellotti, Jonathan M. Flanagan, Lisa Bouchier‐Hayes	29
8	Refractory autoimmune cytopenias in pediatric Evans syndrome with underlying systemic immune dysregulation 2021 ·European Journal Of Haematology ·Amanda B. Grimes, (unknown), Susan E. Kirk, Jonathan M. Flanagan, Michele P. Lambert, Rachael F. Grace, Jenny M. Despotovic	12
9	Tripartite collaboration of blood‐derived endothelial cells, next generation RNA sequencing and bioengineered vessel‐chip may distinguish vasculopathy and thrombosis among sickle cell disease patients 2021 ·Bioengineering & Translational Medicine ·Tanmay Mathur, Jonathan M. Flanagan, Abhishek Jain	12
10	Genetic variants in toll‐like receptor 4 are associated with lack of steroid‐responsiveness in pediatric ITP patients 2020 ·American Journal of Hematology ·(unknown), Jonathan M. Flanagan, (unknown), (unknown), Michele P. Lambert, Rachael F. Grace, Jenny M. Despotovic	5
11	GSTM1 and Liver Iron Content in Children with Sickle Cell Anemia and Iron Overload 2019 ·Journal of Clinical Medicine ·(unknown), Jonathan M. Flanagan, Guolian Kang, (unknown), Wenjian Bi, (unknown), Ralf B. Loeffler, Aaryani Tipirneni‐Sajja, (unknown), Kristine R. Crews, Claudia M. Hillenbrand, Jane S. Hankins	2
12	The Genetic Landscape of Cerebral Steno-Occlusive Arteriopathy and Stroke in Sickle Cell Anemia 2018 ·Journal of Stroke and Cerebrovascular Diseases ·Catherine Amlie‐Lefond, Jonathan M. Flanagan, Julie Kanter, William B. Dobyns	3
13	Whole‐exome sequencing of sickle cell disease patients with hyperhemolysis syndrome suggests a role for rare variation in disease predisposition 2017 ·Transfusion ·Savannah Mwesigwa, Joann M. Moulds, Alice P. Chen, Jonathan M. Flanagan, Vivien Sheehan, Alex George, Neil A. Hanchard	19
14	The role of BCL11A and HMIP-2 polymorphisms on endogenous and hydroxyurea induced levels of fetal hemoglobin in sickle cell anemia patients from southern Brazil 2016 ·Blood Cells Molecules and Diseases ·João Ricardo Friedrisch, Vivien Sheehan, Jonathan M. Flanagan, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Liane Esteves Daudt, Lúcia Mariano da Rocha Silla	20
15	Genetic Modifiers of White Blood Cell Count, Albuminuria and Glomerular Filtration Rate in Children with Sickle Cell Anemia 2016 ·PLoS ONE ·Beverly A. Schaefer, Jonathan M. Flanagan, Ofelia Álvarez, Stephen C. Nelson, Banu Aygün, Kerri Nottage, Alex George, Carla W. Roberts, Connie M. Piccone, Thad A. Howard, Barry R. Davis, Russell E. Ware	27
16	Whole Exome Sequencing Identifies Novel Genes for Fetal Hemoglobin Response to Hydroxyurea in Children with Sickle Cell Anemia 2014 ·PLoS ONE ·Vivien Sheehan, Jacy R. Crosby, Aniko Sabo, Nicole A. Mortier, Thad A. Howard, Donna M. Muzny, Shannon Dugan‐Perez, Banu Aygün, Kerri Nottage, Eric Boerwinkle, Richard A. Gibbs, Russell E. Ware, Jonathan M. Flanagan	28
17	Pain and other non‐neurological adverse events in children with sickle cell anemia and previous stroke who received hydroxyurea and phlebotomy or chronic transfusions and chelation: Results from the SWiTCH clinical trial 2013 ·American Journal of Hematology ·Ofelia Álvarez, Nancy A. Yovetich, John P. Scott, William Owen, Scott T. Miller, William H. Schultz, Alexandre Lockhart, Banu Aygün, Jonathan M. Flanagan, Melanie J. Bonner, Brigitta U. Mueller, Russell E. Ware	39
18	Genetic modifiers of sickle cell anemia in the BABY HUG cohort: influence on laboratory and clinical phenotypes 2013 ·American Journal of Hematology ·Vivien Sheehan, Zhaoyu Luo, Jonathan M. Flanagan, Thad A. Howard, Bruce Thompson, Winfred C. Wang, Abdullah Kutlar, Russell E. Ware, (unknown)	67
19	Genotoxicity associated with hydroxyurea exposure in infants with sickle cell anemia: Results from the BABY‐HUG phase III clinical trial 2011 ·Pediatric Blood & Cancer ·Patrick T. McGann, Jonathan M. Flanagan, Thad A. Howard, Stephen D. Dertinger, Jin He, Anita S. Kulharya, Bruce Thompson, Russell E. Ware, (unknown)	37
20	Characterization of Cytoplasmic Caspase-2 Activation by Induced Proximity 2009 ·Molecular Cell ·Lisa Bouchier‐Hayes, Andrew Oberst, Gavin P. McStay, Samuel Connell, Stephen W. G. Tait, Christopher P. Dillon, Jonathan M. Flanagan, Helen M. Beere, Douglas R. Green	115

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact